Antonia Andreu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Antonia Andreu has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
James R. Johnson
Veterans Affairs Medical Center and University of Minnesota, Minneapolis, MN, USA
2 shared publications- Juan José González-López
Vall d'Hebron Institut de Recerca, Vall d'Hebron Barcelona Hospital Campus, Spain
2 shared publications - Teresa Pérez-Berezo
Microbiology Department, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
2 shared publications - Alicia Coelho
Servicio de Microbiologia, Hospital Vall d'Hebron, 08035 Barcelona, Spain
1 shared publication - Amparo Coira
Department of Clinical Microbiology, Hospital Lucus Augusti, Lugo, Spain
1 shared publication - Beatriz Mirelis
Servicio de Microbiología, Hospital de la Santa Creu i Sant Pau, Barcelona, España; Universitat Autònoma de Barcelona, España; Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III, Madrid, España; Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau), Barcelona, España
1 shared publication
Latest Publications
- 1 January 2011
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 29 (1) , 52-57
Diagnóstico microbiológico de las infecciones del tracto urinario
- 1 January 2011
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 29 (1) , 52-57
Diagnóstico microbiológico de las infecciones del tracto urinario
- 31 October 2010
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 28, 63-68
Unificación de los laboratorios: aportaciones y desventajas para la microbiología clínica
- 31 October 2010
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 28, 63-68
Unificación de los laboratorios: aportaciones y desventajas para la microbiología clínica
- 1 April 2008
- Published by Elsevier in Medicina Clinica
- Vol. 130 (13) , 481-486
Etiología de la infección urinaria baja adquirida en la comunidad y resistencia de Escherichia coli a los antimicrobianos de primera línea. Estudio nacional multicéntrico
- 1 April 2008
- Published by Elsevier in Medicina Clinica
- Vol. 130 (13) , 481-486
Etiología de la infección urinaria baja adquirida en la comunidad y resistencia de Escherichia coli a los antimicrobianos de primera línea. Estudio nacional multicéntrico
- Open Access
- 1 September 2006
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 12 (9) , 880-886
Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates
- 1 September 2006
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 12 (9) , 880-886
Open AccessPathogenicity island markers in commensal and uropathogenic Escherichia coli isolates
- Open Access
- 3 January 2006
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (2) , 204-211
Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli
Introduction: The goal of this study was to assess how resistance to quinolones, fluoroquinolones and trimethoprim/sulfamethoxazole relates to the virulence potential and phylogenetic background of clinical Escherichia coli isolates. Methods: Among 150 uropathogens (21% resistant to quinolones, 12% resistant to fluoroquinolones and 29.3% resistant to trimethoprim/sulfamethoxazole), E. coli phylogenetic group, 15 virulence-associated genes and 7 O antigens were analysed. Clonal group A (CGA) and genomic PCR profiles were studied among trimethoprim/sulfamethoxazole-resistant isolates. Results: Isolates susceptible to the three antimicrobial agents were significantly associated with phylogenetic group B2, whereas resistant isolates exhibited shifts to non-B2 groups (quinolone and fluoroquinolone-resistant isolates to group A; trimethoprim/sulfamethoxazole-resistant isolates to group D). Diverse virulence traits, including UTI-associated O antigens, were significantly less frequent among resistant isolates, particularly those resistant to fluoroquinolones (median score, 3.9 virulence factors/strain) and also to quinolones (5.2) or trimethoprim/sulfamethoxazole (6.4), as compared with the corresponding drug-susceptible isolates (median scores of 7.9, 8.6 and 7.9, respectively). Among 44 trimethoprim/sulfamethoxazole-resistant isolates, 3 (6.8%) belonged to CGA. All these 3 CGA strains caused pyelonephritis (P = 0.02) and exhibited the consensus virulence profile of previously described CGA strains from abroad. Conclusions: E. coli isolates resistant to quinolones, trimethoprim/sulfamethoxazole and especially fluoroquinolones were associated with reductions in virulence traits and shifts to non-B2 phylogenetic groups. Moreover, fluoroquinolone resistance usually occurred in low-virulence E. coli group A isolates rather than in isolates from groups B2 and D which had lost virulence traits. CGA accounted for 23% of trimethoprim/sulfamethoxazole-resistant E. coli producing pyelonephritis.
- 3 January 2006
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (2) , 204-211
Open AccessQuinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli
Introduction: The goal of this study was to assess how resistance to quinolones, fluoroquinolones and trimethoprim/sulfamethoxazole relates to the virulence potential and phylogenetic background of clinical Escherichia coli isolates. Methods: Among 150 uropathogens (21% resistant to quinolones, 12% resistant to fluoroquinolones and 29.3% resistant to trimethoprim/sulfamethoxazole), E. coli phylogenetic group, 15 virulence-associated genes and 7 O antigens were analysed. Clonal group A (CGA) and genomic PCR profiles were studied among trimethoprim/sulfamethoxazole-resistant isolates. Results: Isolates susceptible to the three antimicrobial agents were significantly associated with phylogenetic group B2, whereas resistant isolates exhibited shifts to non-B2 groups (quinolone and fluoroquinolone-resistant isolates to group A; trimethoprim/sulfamethoxazole-resistant isolates to group D). Diverse virulence traits, including UTI-associated O antigens, were significantly less frequent among resistant isolates, particularly those resistant to fluoroquinolones (median score, 3.9 virulence factors/strain) and also to quinolones (5.2) or trimethoprim/sulfamethoxazole (6.4), as compared with the corresponding drug-susceptible isolates (median scores of 7.9, 8.6 and 7.9, respectively). Among 44 trimethoprim/sulfamethoxazole-resistant isolates, 3 (6.8%) belonged to CGA. All these 3 CGA strains caused pyelonephritis (P = 0.02) and exhibited the consensus virulence profile of previously described CGA strains from abroad. Conclusions: E. coli isolates resistant to quinolones, trimethoprim/sulfamethoxazole and especially fluoroquinolones were associated with reductions in virulence traits and shifts to non-B2 phylogenetic groups. Moreover, fluoroquinolone resistance usually occurred in low-virulence E. coli group A isolates rather than in isolates from groups B2 and D which had lost virulence traits. CGA accounted for 23% of trimethoprim/sulfamethoxazole-resistant E. coli producing pyelonephritis.
- Open Access
- 1 June 2005
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (6) , 2525-2527
Multicenter Study of the Mechanisms of Resistance and Clonal Relationships of Streptococcus agalactiae Isolates Resistant to Macrolides, Lincosamides, and Ketolides in Spain
Macrolide, lincosamide, and ketolide mechanisms of resistance and clonal relationships were characterized in a collection of 79 resistant group B streptococcus isolates obtained from neonates or pregnant women. The erm (B), erm (TR), and mef (A) genes were present in 62%, 30.4%, and 3.8% of the isolates, respectively. There was considerable clonal diversity among them.
- 1 June 2005
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (6) , 2525-2527
Open AccessMulticenter Study of the Mechanisms of Resistance and Clonal Relationships of Streptococcus agalactiae Isolates Resistant to Macrolides, Lincosamides, and Ketolides in Spain
Macrolide, lincosamide, and ketolide mechanisms of resistance and clonal relationships were characterized in a collection of 79 resistant group B streptococcus isolates obtained from neonates or pregnant women. The erm (B), erm (TR), and mef (A) genes were present in 62%, 30.4%, and 3.8% of the isolates, respectively. There was considerable clonal diversity among them.